How Private Equity Is Buying Up Independent Pharmacies

In this episode of The Buyout Show, Lucas and Luna examine a quiet roll-up wave sweeping America: private equity's acquisition of independent retail pharmacies. They focus on the specific case of CAP Rx, a portfolio company formed by private equity firm Alpine Investors that has acquired over 40 independent pharmacies since 2021. Lucas breaks down the deal mechanics — how consolidators use a 'central fill' model to cut costs, how they negotiate with pharmacy benefit managers for better reimbursement rates, and why the average independent pharmacy sells for 4 to 6 times EBITDA. Luna raises the tension between efficiency and community care: when a pharmacy is owned by a private equity-backed roll-up, does the patient experience change? They discuss the regulatory guardrails — state boards of pharmacy that require a licensed pharmacist to own at least 51 percent in some states, and how deals are structured around 'management services organizations' to work around that. The episode closes on the question of whether these roll-ups are building lasting businesses or financial engineering plays. No prior episode has covered this specific consolidation trend. #PrivateEquity #PharmacyRollUp #IndependentPharmacies #CAPRx #AlpineInvestors #PharmacyBenefitManagers #CentralFill #MSOModel #HealthcareM&A #PharmacyConsolidation #Business #FexingoBusiness #BusinessPodcast #TheBuyoutShow #RetailPharmacy #EBITDA #RegulatoryHurdles #CommunityPharmacy Keep every episode free: buymeacoffee.com/fexingo